Document Classification

Section Type: METHODS

Text: A total of 342 H. pylori-positive adult patients from primary health care referred for gastroscopy at 23 centres in different parts of Finland were randomized to receive either (i) lansoprazole 30 mg b. d., amoxicillin 1 g b. d. and metronidazole 400 mg t. d. s. (LAM), (ii) lansoprazole 30 mg b. d., amoxicillin 1 g b. d. and clarithromycin 500 mg b. d. (LAC), or (iii) ranitidine bismuth citrate 400 mg b. d., metronidazole 400 mg t. d. s. and tetracycline 500 mg q. d. s. (RMT).